ARTICLE | Clinical News
EcoNail: Phase II data
July 28, 2008 7:00 AM UTC
In an open-label, 48-week, U.S. Phase II trial (MCHM EC-200) of EcoNail, none of the 37 patients met the composite primary efficacy endpoint of complete cure, defined as negative mycology and clear na...